Skip to record
ExecutivesAnthony Bergmann, M.B.A.

Executive record

Anthony Bergmann, M.B.A.

Public governance roles and source-backed Claims for this individual.

Follow record
More
Challenge a Claim

Alpha ID: alpha:person:anthony-bergmann-m-b-a-caprVersion: public-0As of: 2026-10-01

Not yet claimed9 published Claims2 sources

Leadership, in context.

Connect capital, control, accountability, and evidence.

Published Claims9Within this recordEvidence sources2Inspect provenance and dates

Explore the record

ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.

Key Claims

Biography

Mr. Bergmann has served as Capricor Therapeutics' CFO since 2018 and has been involved in the biotechnology industry for approximately 15 years, overseeing the company's entry into public markets and leading equity financings totaling over $500 million. Prior to Capricor, he worked at Gettleson, Witzer and O'Connor, a Beverly Hills-based business and financial management firm serving entertainment industry clients.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.